J2281 Injection moxifloxacin (fres kabi)
Also known as: moxifloxacin, Fresenius Kabi moxifloxacin
Injection of moxifloxacin (Fresenius Kabi brand). A fluoroquinolone antibiotic from a specific manufacturer.
In Plain Language
antibiotic injection; infection treatment
Clinical Context
Identical clinical use to standard moxifloxacin for bacterial infections. Fresenius Kabi is a specific manufacturer of IV moxifloxacin.
RVU Information
CPT J2281 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2281?
CPT J2281 (Injection moxifloxacin (fres kabi)) is a J Codes (Drugs) code. Injection of moxifloxacin (Fresenius Kabi brand). A fluoroquinolone antibiotic from a specific manufacturer.
How is J2281 administered?
CPT J2281 is administered by a healthcare provider, typically via injection or infusion. Identical clinical use to standard moxifloxacin for bacterial infections. Fresenius Kabi is a specific manufacturer of IV moxifloxacin. It is used by Infectious Disease, Internal Medicine.
When is CPT J2281 used?
Identical clinical use to standard moxifloxacin for bacterial infections. Fresenius Kabi is a specific manufacturer of IV moxifloxacin.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.